Mydecine Innovations Group (TSE:MYCO)
CNQX:MYCO

Mydecine Innovations Group (MYCO) Financial Statements

92 Followers

Mydecine Innovations Group Financial Overview

Mydecine Innovations Group's market cap is currently ―. The company's EPS TTM is C$-0.366; its P/E ratio is -0.04; Mydecine Innovations Group is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -665.22KC$ 1.23MC$ -2.94MC$ -7.42MC$ -5.88M
EBITDAC$ -665.22KC$ 1.23MC$ -2.94MC$ -7.41MC$ -5.87M
Net Income Common StockholdersC$ -1.02MC$ 1.36MC$ -3.18MC$ -7.65MC$ -155.96K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 20.35KC$ 37.65KC$ 40.46KC$ 565.71KC$ 4.63M
Total AssetsC$ 213.41KC$ 212.38KC$ 1.03MC$ 2.22MC$ 6.90M
Total DebtC$ 5.78MC$ 5.42MC$ 5.25MC$ 5.02MC$ 4.78M
Net DebtC$ 5.76MC$ 5.39MC$ 5.21MC$ 4.45MC$ 153.26K
Total LiabilitiesC$ 13.05MC$ 12.13MC$ 10.11MC$ 10.27MC$ 10.50M
Stockholders EquityC$ -12.84MC$ -11.92MC$ -9.08MC$ -8.05MC$ -3.60M
Cash Flow-
Free Cash FlowC$ -17.30KC$ 951.81KC$ -2.15MC$ -3.00MC$ -1.25M
Operating Cash FlowC$ -17.30KC$ 951.81KC$ -2.15MC$ -3.00MC$ -1.25M
Investing Cash Flow-C$ 1.00C$ 25.20KC$ 500.00KC$ -2.08K
Financing Cash Flow-C$ -931.50KC$ 2.13MC$ 2.50MC$ 1.17M
Currency in CAD

Mydecine Innovations Group Earnings and Revenue History

Mydecine Innovations Group Debt to Assets

Mydecine Innovations Group Cash Flow

Mydecine Innovations Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis